Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients.
暂无分享,去创建一个
F. Goldwasser | S. Oudard | F. Joly | F. Scotté | P. Beuzeboc | J. Ferrero | J. Andrieu | J. Medioni | E. Banu | A. Banu | Florence Joly | François Goldwasser | Jean-Marie Andrieu